Back
Zimmer Biomet Holdings Vs. Biomarin Pharmaceutical Industry Stock Comparison
Buy
80
ZBH
Zimmer Biomet Holdings
Last Price:
$109.56
Seasonality Move:
3.8%
Buy
52
BMRN
Biomarin Pharmaceutical
Last Price:
$61.53
Seasonality Move:
-2.99%
Buy
80
Zimmer Biomet Holdings (ZBH)
is a Buy
Is Zimmer Biomet Holdings a Buy, Sell or Hold?
-
The current Zimmer Biomet Holdings [ZBH] share price is $109.56. The Score for ZBH is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
ZBH is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
-
The current Biomarin Pharmaceutical [BMRN] share price is $61.53. The Score for BMRN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ZBH Stock Price Chart
What is Zimmer Biomet Holdings's stock price today?
-
The Zimmer Biomet Holdings share price today is $109.56Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZBH is experiencing slight buying pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $61.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.
ZBH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.17 | Sell |
Relative Strength Index (14 RSI): | 60.95 | Buy |
Chaikin Money Flow: | 490722 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.24 - 107.78) | Buy |
Bollinger Bands (100): | (104.23 - 110.83) | Buy |
BMRN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.87 | Sell |
Relative Strength Index (14 RSI): | 32.71 | Sell |
Chaikin Money Flow: | -1783794 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (63.88 - 67.6) | Sell |
Bollinger Bands (100): | (62.43 - 78.09) | Sell |
ZBH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 105.55 | Buy |
20-day SMA: | 105.75 | Buy |
50-day SMA: | 108.03 | Buy |
200-day SMA: | 111 | Sell |
8-day EMA: | 106.66 | Buy |
20-day EMA: | 106.27 | Buy |
50-day EMA: | 106.99 | Buy |
200-day EMA: | 110.73 | Sell |
BMRN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.85 | Sell |
20-day SMA: | 65.63 | Sell |
50-day SMA: | 65.49 | Sell |
200-day SMA: | 77.22 | Sell |
8-day EMA: | 63.78 | Sell |
20-day EMA: | 65.11 | Sell |
50-day EMA: | 66.54 | Sell |
200-day EMA: | 75.24 | Sell |
Zimmer Biomet Holdings Earnings Growth & ZBH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.58 per share, and an increase next year of $0.65 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.88 per share, and an increase next year of $1.02 per share.
Zimmer Biomet Holdings Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Biomarin Pharmaceutical Technical Analysis
Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |